Cancer News and Research

Latest Cancer News and Research

AstraZeneca announces encouraging results from olaparib phase II study in serous ovarian cancer

AstraZeneca announced today encouraging results from a phase II study in patients with platinum-sensitive relapsed serous ovarian cancer (SOC) who had received maintenance treatment with the investigational drug olaparib, after the completion of chemotherapy.

19 May 2011

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Use of a simple, at-home screening test by Canadians can prevent many unnecessary colorectal cancer deaths, according to a special report about colorectal cancer in Canadian Cancer Statistics 2011 released today by the Canadian Cancer Society, in collaboration with the Public Health Agency of Canada and Statistics Canada.

19 May 2011

Affymetrix launches new Axiom myDesign TG Arrays for targeted genotyping market

Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.

19 May 2011

Free NYU Physician iPad app now available in iTunes store

NYU Langone Medical Center, one of the nation's premier academic medical centers, announced today the magazine of NYU School of Medicine, NYU Physician, is now available as a free iPad app in the iTunes App Store.

19 May 2011

New technique offers successful bone marrow, organ transplant for patients with autoimmune diseases

University of Minnesota Medical School researchers have discovered a method to quickly and exponentially grow regulatory T-cells - also known as "suppressor cells." The new process enables replication of the cells by tens of millions in several weeks, a dramatic increase over previous duplication methods. Historically, regulatory T-cells have been difficult to replicate.

19 May 2011

Low calorie sweeteners offer effective solution to manage weight

The desire to eat sweet things does not need to be suppressed, just managed, according to health and nutrition experts meeting at the International Sweeteners Association's conference in Brussels today.

19 May 2011

Hospital websites use industry-provided content and overestimate claims of surgical robots

An estimated four in 10 hospital websites in the United States publicize the use of robotic surgery, with the lion's share touting its clinical superiority despite a lack of scientific evidence that robotic surgery is any better than conventional operations, a new Johns Hopkins study finds.

19 May 2011

Study: 10% of cancer patients fail to fill initial oral oncolytic prescriptions

Ten percent of cancer patients failed to fill their initial prescriptions for oral anti-cancer drugs, according to a new study published jointly today in the Journal of Oncology Practice and American Journal of Managed Care.

19 May 2011

Humanized BLT mice help prevent HIV/AIDS transmission

The more than 2.7 million new HIV infections recorded per year leave little doubt that the HIV/AIDS epidemic continues to spread globally. That's why there's the need for safe, inexpensive and effective drugs to successfully block HIV transmission.

19 May 2011

On Op-Ed pages, controversies abound: Romney, Gingrich, abortion, telemedicine, cancer funding cuts

Gingrich was taking basically the same position on Medicare he took 16 years ago, when, as speaker of the House, he was the commanding general of the Republican Revolution. ... Compared to today's Republican agenda, the Revolution of '94 now appears to be a halcyon period of moderation and good sense. Then, there was a hope that government-run Medicare would "wither on the vine" when recipients were offered alternatives.

19 May 2011

Simple lymphocyte count effectively identifies prognosis of renal cell carcinoma

Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health problems. Unfortunately, the prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated.

19 May 2011

NEW Lifestyle on-line teaching modules for medical students

Obesity is an epidemic and when paired with physical inactivity it represents the second leading cause of preventable death nationally from cancer, cardiovascular diseases and diabetes. But in medical school, there is a training gap when it comes to teaching future doctors about obesity and related health problems.

19 May 2011

Rally Foundation distributes $700,000 nationwide to support childhood cancer research

Rally Foundation, a national non-profit organization committed to research to fight childhood cancer, has announced its annual funding allocation for 2011 and has selected 15 hospitals across the country to receive more than $700,000.

19 May 2011

Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting

Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.

19 May 2011

Generic drugs to rule the market in the near future: Experts

According to the latest estimates for global drug sales, generic drug makers are going to be in for bumper profits. The growth in generics is expected to depress overall ‘pharma’ sales growth, as lower-priced copies replace top-dollar brand names. In fact, global sales growth could be reduced by half over the next five years, say experts.

19 May 2011

Allergy towards electricity after chemotherapy

Janice Tunnicliffe, 55 has become allergic to electromagnetic fields and electricity after a course of chemotherapy for bowel cancer. Fortunately, despite the size of the tumor, her cancer had not spread, but it was decided that she should have chemotherapy after the surgery as a precautionary measure.

19 May 2011

Scientists identify key protein behind drug-resistant leukemia

Acute lymphoblastic leukemia, or ALL, is the most common form of childhood cancer. While most children treated for this disease survive, in a subgroup of patients the disease does not respond to treatment.

19 May 2011

APP receives FDA approval to market Gemcitabine HCI for Injection, USP in 2 g dosage

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Gemcitabine HCI for Injection, USP, in the 2 g dosage strength. APP will launch this presentation of Gemcitabine immediately.

19 May 2011

Two genes linked to worst cases of esophageal cancer

University of Rochester Medical Center researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes.

19 May 2011

MDC researchers comprehensively quantify gene expression for the first time

How do genes control us? This fundamental question of life still remains elusive despite decades of research. Genes are blueprints for proteins, but it is the proteins that actually carry out vital functions in the body for maintaining life. Diseases such as cancer are not only characterized by altered genes, but also by disturbed protein production.

19 May 2011

Cancer News and Research

Latest Cancer News and Research

AstraZeneca announces encouraging results from olaparib phase II study in serous ovarian cancer

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Affymetrix launches new Axiom myDesign TG Arrays for targeted genotyping market

Free NYU Physician iPad app now available in iTunes store

New technique offers successful bone marrow, organ transplant for patients with autoimmune diseases

Low calorie sweeteners offer effective solution to manage weight

Hospital websites use industry-provided content and overestimate claims of surgical robots

Study: 10% of cancer patients fail to fill initial oral oncolytic prescriptions

Humanized BLT mice help prevent HIV/AIDS transmission

On Op-Ed pages, controversies abound: Romney, Gingrich, abortion, telemedicine, cancer funding cuts

Simple lymphocyte count effectively identifies prognosis of renal cell carcinoma

NEW Lifestyle on-line teaching modules for medical students

Rally Foundation distributes $700,000 nationwide to support childhood cancer research

Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting

Generic drugs to rule the market in the near future: Experts

Allergy towards electricity after chemotherapy

Scientists identify key protein behind drug-resistant leukemia

APP receives FDA approval to market Gemcitabine HCI for Injection, USP in 2 g dosage

Two genes linked to worst cases of esophageal cancer

MDC researchers comprehensively quantify gene expression for the first time

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in